Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Horizon Europe, the incoming EU framework programme for research, will soon succeed Horizon 2020. This will have a direct impact on EU funds available for health research in the future. Under Horizon Europe the ESC is calling for CVD-specific calls to tackle the burden of disease and drive excellence in research.
The Strategic Research Agenda for Cardiovascular Diseases (SRA-CVD) developed by ERA-CVD, a European Research Area Network (ERA-NET), is a blueprint for shaping CVD research priorities in Horizon Europe.
The ESC has significantly contributed as a member of the Advisory Board of ERA CVD. This Strategic Research Agenda (SRA) proposes 15 topics for CVD research in three categories: prevention strategies; treatment and management; and living with chronic cardiovascular diseases.
Among the topics are:
There is false optimism that cardiovascular disease (CVD) is no longer a major public health problem. In Europe, more than 10,000 patients die of CVD every day. CVD is expected to remain the top reason for death, premature death and disease burden in Europe over the next 20 years.
ERA–CVD is conducting an online survey for patients, the public, healthcare providers and research scientists to rank the 15 topics in order to identify the most pressing research priorities.
Implementation of the proposed research agenda will require action at EU and national level from ministries, funding agencies, healthcare administrators and the private sector.
ESC Press Release
Our Mission: To Reduce the Burden of Cardiovascular Disease
© 2019 European Society of Cardiology. All rights reserved